An African American Male With Vision Problems and Motor Weakness

Neurology | March 15, 2021

Credits:

Not Available Click to Register/login And Complete Your Free Webcourse

Launch Date:

March 15, 2021

Expiration Date:

March 15, 2022

primary audience:

Ms nurse practitioners and nurses, Ms physician assistants, Ms specialists, Neurologists, Neurology nurse practitioners and nurses, Neurology physician assistants

Relevant Terms:

Ms, Multiple sclerosis

course faculty

Mariko Kita, MD

Dr Mariko Kita received her bachelor’s degree in biology from Johns Hopkins University and her medical degree from Northwestern University School of Medicine. She completed her internship in internal medicine at Northwestern Memorial Hospital and her residency in neurology at the Hospital of the University of Pennsylvania. Dr Kita completed her fellowship in neuroimmunology at Mt. Zion Multiple Sclerosis Center, University of California School of Medicine. She joined Virginia Mason Medical Center and Benaroya Research Institute at Virginia Mason in 2000. Dr Kita is currently Chief of Medicine, Virginia Mason Medical Center; Director, Virginia Mason Multiple Sclerosis Center; and Director, Neurology Clinical Trials, Benaroya Research Institute.

Denise Bruen, ANP-BC, MSCN

A Virginia native, Denise Bruen grew up in Reston, VA. She attended the University of Virginia for nursing and graduated in 1996. She then received her master’s degree in nursing from Rush University in Chicago, IL, in 2004.

Ms Bruen is an adult nurse practitioner and certified multiple sclerosis nurse. She specializes in caring for those living with MS. Ms Bruen has been a nurse practitioner at the University of Virginia since 2004 and has worked at the Multiple Sclerosis Clinic since 2010. She is the medical director for the Multiple Sclerosis Clinic and past president of the International Organization of Multiple Sclerosis Nurses.

learning objectives

1. APPLY the McDonald criteria to ensure an early and accurate diagnosis of MS

2. SELECT patients who may derive benefit from early initiation of high-efficacy DMT to reduce disability in patients with MS

course information

SPONSORSHIP & SUPPORT

This educational activity is jointly provided by the American Academy of CME and Spire Learning.

This activity is supported by educational grants from Biogen Inc. and Novartis Pharmaceuticals Corporation.

PROGRAM OVERVIEW

Multiple sclerosis (MS) is a chronic neurodegenerative disease with a complex clinical course, and many health care professionals may miss opportunities to deliver evidence-based care. Join our expert faculty as they discuss patient scenarios to highlight methods to avoid missed opportunities for the care team to provide optimal care for patients with MS.

TARGET AUDIENCE

MS specialists, MS physician assistants, MS nurse practitioners and nurses, neurologists, neurology physician assistants, neurology nurse practitioners and nurses

LEARNING OBJECTIVES

Upon completion of this educational activity, learners should be better able to:

APPLY the McDonald criteria to ensure an early and accurate diagnosis of MS
SELECT patients who may derive benefit from early initiation of high-efficacy DMT to reduce disability in patients with MS

ACCREDITATION AND CREDIT DESIGNATION

In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and Spire Learning. American Academy of CME, Inc., is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: American Academy of CME, Inc., designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NPs/Nurses: American Academy of CME, Inc., designates this educational activity for 0.25 ANCC contact hours (0.1 pharmacotherapeutic contact hours).

PAs: Per the AAPA, PAs attending an educational activity that has been designated for AMA PRA Category 1 Credit™ may claim up to the maximum number of credits designated.

HOW TO RECEIVE CREDIT

To receive credit for your participation in this educational activity:

Read the objectives and other introductory CME information
Complete the preassessment prior to the start of the activity
Participate in the MS case activity
Complete the postassessment and evaluation at the conclusion of the activity

If you are seeking credit, you must complete the evaluation at the conclusion of the activity.

CONFLICT OF INTEREST STATEMENT

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence.

PLANNING COMMITTEE CO-CHAIRS

Mariko Kita, MD

Chief of Medicine

Virginia Mason Medical Center

Director, Neurology Clinical Trials

Benaroya Research Institute

Seattle, WA

Disclosure Statement:

Advisory Board – for scientific information: Biogen Inc; EMD Serono

Promotional Speakers Bureau: Biogen Inc; EMD Serono

Denise Bruen, ANP-BC, MSCN

University of Virginia

James Q. Miller Consultative MS Center

Charlottesville, VA

Disclosure Statement:

Advisory Board – for marketing purposes: Biogen Inc; Genentech Inc; Life Sciences; Novartis Pharmaceuticals Corporation; Sanofi Genzyme

Advisory Board – for scientific information: Genentech Inc; Novartis Pharmaceuticals Corporation; Sanofi Genzyme

EDUCATIONAL PLANNING COMMITTEE

American Academy of CME, Inc.

John Juchniewicz, MCIS, CHCP, Natalie Kirkwood, RN, BSN, JD: No relevant financial relationships with any commercial interests.

Spire Learning

Mairead Early has nothing to disclose.

Jeanne Prater discloses the following:

Employee (spouse): Novo Nordisk Inc; Shareholder (spouse): Johnson & Johnson

Christopher Washburn, PhD, discloses the following:

Employee (spouse): Janssen Pharmaceuticals, Inc

Reviewer

Kathleen Costello, MS, ANP-BC, MSCN, MSCS: No relevant financial relationships with any commercial interests.

OFF-LABEL STATEMENT

The faculty does not discuss non–FDA-approved or investigational agents for the treatment of multiple sclerosis (MS).

DISCLAIMER

The opinions expressed in this educational activity are those of the faculty and do not represent those of the Academy or Spire Learning. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, consult appropriate resources for any product or device mentioned in this activity, and draw conclusions only after careful consideration of all available scientific information.

PRIVACY
For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm

Spire Learning Privacy Policy:
Spire Learning, LLC is committed to protecting the privacy of personal information from our participants and educational collaborators. Spire maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of personal information.

Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing an activity. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of each activity. All evaluative information submitted is collected and retained, and used by Spire Learning, LLC to continuously improve the learning experience.

Spire Learning, LLC will not transfer, sell, or share personal information with outside parties or otherwise disclose personal information unless required to in a legal process. Spire will retain your personal data only for the period necessary to accomplish the stated purposes and to comply with applicable laws.

COPYRIGHT INFORMATION
Copyright © 2021 by Spire Learning, LLC and its Licensors. All rights reserved. No part of this publication or activity may be reproduced or transmitted in any form, by any means, without prior written permission of Spire Learning, LLC. Spire Learning, LLC and the American Academy of CME will not assume responsibility for damages, loss, or claims of any kind arising from or related to the information contained in this publication or activity, including any claims related to the products, drugs, or services mentioned herein.

CONTACT

For any questions, please contact: CEServices@academycme.org

COURSE VIEWING REQUIREMENTS

Supported Browsers: Microsoft Edge Google Chrome 60 or higher Mozilla Firefox 60 or higher Apple Safari 11.0 or higher For video, install the latest version of Quicktime.	Supported Phones & Tablets: iOS 9.3 and higher Android 7.0 (Nougat or higher) Microsoft Windows 8 Chrome OS
Additional Recommendations and Requirements
Display Resolution & Color Depth	Resolution – 960 X 768 minimum – 1024 X 768 recommended min. Color Depth – 8 bits (256 colors) minimum – 16 bits (High colors) minimum
Audio	– Microphone – Speakers or headphones – Audio recording support
Word Processing	Software that can open, modify, and save documents in Rich Text Format (RTF). Microsoft Word and PowerPoint are recommended.

Click to Register/login And Complete Your Free Webcourse

An African American Male With Vision Problems and Motor Weakness

Credits:

Launch Date:

Expiration Date:

primary audience:

Relevant Terms:

Mariko Kita, MD

Denise Bruen, ANP-BC, MSCN

Related Courses

Understanding the Importance of Screening and Utility of Clinical Asse...

Launches:

Expires:

Improving Screening and Diagnosis of Alzheimer's Disease

Launches:

Expires:

A Closer Look Into Validated Cognitive Assessment Tools for Multiple D...

Launches:

Expires:

Engage And Grow